- Investor Relations Asia Pacific

CSPC Pharmaceutical Group Limited
(Incorporated in Hong Kong with limited liability)

Press Releases       

Please download the latest "Acrobat Reader" to view the PDF.

  • 2020-August-26
  • CSPC Pharmaceutical Announces 2020 Interim Results, Profit Attributable to Shareholders Increased 23.2% to RMB2,314 Million, Declared an Interim Dividend of HK6 Cents Per Share, Proposed a Bonus Issue of 3 Bonus Shares for Every 5 Existing Shares Held (in PDF)
  • 2020-March-30
  • CSPC Pharmaceutical Announces 2019 Annual Results, Profit Attributable to Shareholders Increased 20.6% to RMB3,714 Million, Innovative Drug Business Continued to Deliver Strong Growth, New Products Launched Helped to Sustain Growth (in PDF)
  • 2019
  • 2019 Press Releases
  • 2018
  • 2018 Press Releases
  • 2017
  • 2017 Press Releases
  • 2016
  • 2016 Press Releases

  • Company's Index

  • About   |   Terms of Use   |   Privacy Policy Statement   |   Disclaimer
    © Copyright 1996-2024 Ltd. All rights reserved.
    DISCLAIMER: Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall Ltd. be liable for damages resulting from the use of the information provided on this website.
    Cookie Policy

    This website uses cookies. Please refer to our Cookie Notice and Privacy Notice for further information. By continuing to use this website, you agree to our use of cookies.